Publication | Open Access

Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial

VaccinologyVaccine SafetyVaccinationVaccine DevelopmentVaccine SurveillanceImmunologyHeterologous BoosterVaccine EfficacyMedicineVaccine ResearchCovid-19Healthy Adults